108 related articles for article (PubMed ID: 11392875)
1. DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Mezza E; Argenziano G; Vetrani A; Lucariello A; Franco R; Errico ME; De Rosa G;
Am J Clin Pathol; 2001 Jun; 115(6):805-13. PubMed ID: 11392875
[TBL] [Abstract][Full Text] [Related]
2. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
4. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
Utikal J; Udart M; Leiter U; Kaskel P; Peter RU; Krähn G
Cancer Lett; 2005 Mar; 219(2):197-204. PubMed ID: 15723720
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy in nonmelanoma skin cancer.
Robinson JK; Rademaker AW; Goolsby C; Traczyk TN; Zoladz C
Cancer; 1996 Jan; 77(2):284-91. PubMed ID: 8625236
[TBL] [Abstract][Full Text] [Related]
7. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy, cyclin D1, bcl-2 and lymphocytic infiltration of the tumor microenvironment as prognostic factors in laryngeal cancer patients.
Ziółkowski A; Olszewski WP; Gabriel A; Namysłowski G; Kobos J; Morawski K; Urbaniec P
Pol J Pathol; 2005; 56(4):171-8. PubMed ID: 16477876
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
11. Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma.
Zhang Z; Liu W; Jia X; Gao Y; Hemminki K; Lindholm B
Clin Chim Acta; 2004 Apr; 342(1-2):137-43. PubMed ID: 15026274
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma.
Janisson-Dargaud D; Durlach A; Lorenzato M; Grange F; Bernard P; Birembaut P
J Cutan Pathol; 2008 Oct; 35(10):916-21. PubMed ID: 18537864
[TBL] [Abstract][Full Text] [Related]
13. Head and neck paragangliomas: a clinicopathologic study with DNA flow cytometric analysis.
Granger JK; Houn HY
South Med J; 1990 Dec; 83(12):1407-12. PubMed ID: 2251529
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
[TBL] [Abstract][Full Text] [Related]
15. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
16. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma.
Adegboyega PA; Rodriguez S; McLarty J
Hum Pathol; 2010 Aug; 41(8):1128-37. PubMed ID: 20381122
[TBL] [Abstract][Full Text] [Related]
17. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
Lim SC
Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
19. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
20. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
